Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery
Launched by FUNDACIO PUIGVERT · Dec 27, 2011
Trial Information
Current as of August 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 18 yrs.
- • Patients undergo laparoscopic urologic surgery
- • Physical status ASA \< 3
- • Surgical procedure without complications
- • Signed informed consent
- Exclusion Criteria:
- • Allergy to bupivacaine chlorhydrate
- • Patients with chronic pain treatment
- • Alcoholism
- • Decompensated hepatic disease
- • Coagulation disorders
- • BMI \> 35
- • Patient involved in another clinical trial
About Fundacio Puigvert
Fundació Puigvert is a leading non-profit organization dedicated to advancing medical research and clinical care in urology, nephrology, and andrology. Based in Barcelona, Spain, the foundation is committed to improving patient outcomes through innovative clinical trials and studies that seek to enhance understanding and treatment of urological and renal diseases. With a multidisciplinary team of experts, Fundació Puigvert fosters collaboration between researchers, clinicians, and healthcare professionals, ensuring that cutting-edge research translates into effective therapeutic strategies. The foundation is recognized for its ethical approach and dedication to patient-centered care, contributing significantly to the global medical community's knowledge and practices in these specialized fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Juan Francisco Mayoral, MD
Principal Investigator
Fundació Puigvert (IUNA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials